Surgery Partners [SGRY] vs Chemed [CHE] Detailed Stock Comparison
Surgery Partners
NASDAQ
Loading...
Chemed
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Surgery Partners wins in 7 metrics, Chemed wins in 12 metrics, with 0 ties. Chemed appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Surgery Partners | Chemed | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 2,956.00 | 22.80 | Chemed |
| Price-to-Book Ratio | 1.54 | 5.37 | Surgery Partners |
| Debt-to-Equity Ratio | 108.74 | 12.15 | Chemed |
| PEG Ratio | -35.47 | -0.97 | Surgery Partners |
| EV/EBITDA | 12.66 | 14.59 | Surgery Partners |
| Profit Margin (TTM) | -5.57% | 11.56% | Chemed |
| Operating Margin (TTM) | 14.68% | 11.00% | Surgery Partners |
| EBITDA Margin (TTM) | 14.68% | 11.00% | Surgery Partners |
| Return on Equity | 0.12% | 24.14% | Chemed |
| Return on Assets (TTM) | 3.92% | 13.56% | Chemed |
| Free Cash Flow (TTM) | $209.70M | $367.97M | Chemed |
| Dividend Yield | N/A | 0.18% | N/A |
| 1-Year Return | -33.06% | -26.19% | Chemed |
| Price-to-Sales Ratio (TTM) | 0.84 | 2.57 | Surgery Partners |
| Enterprise Value | $8.17B | $6.33B | Surgery Partners |
| EV/Revenue Ratio | 2.52 | 2.52 | Chemed |
| Gross Profit Margin (TTM) | 23.67% | 29.85% | Chemed |
| Revenue per Share (TTM) | $26 | $170 | Chemed |
| Earnings per Share (Diluted) | $-1.43 | $19.45 | Chemed |
| Beta (Stock Volatility) | 1.84 | 0.43 | Chemed |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Surgery Partners vs Chemed Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Surgery Partners | -3.59% | -6.94% | -7.65% | -7.44% | -0.59% | -4.23% |
| Chemed | -1.83% | -3.70% | -6.12% | -5.50% | -24.29% | -17.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Surgery Partners | -33.06% | -17.62% | -13.75% | 7.49% | 10.63% | 10.63% |
| Chemed | -26.19% | 0.67% | -12.54% | 230.76% | 651.17% | 961.90% |
News Based Sentiment: Surgery Partners vs Chemed
Surgery Partners
News based Sentiment: NEUTRAL
Surgery Partners reported solid revenue growth and reaffirmed its guidance, but profitability remains a concern. Regulatory changes introduce both opportunities and challenges, creating a balanced investment picture. The upcoming Investor Day will be crucial for clarifying the company's strategy and outlook.
Chemed
News based Sentiment: MIXED
The month of October presented a mixed bag for Chemed, with a slight stock price increase offset by concerning volume trends, a downgrade from StockInvest.us, and a reduced price target from Bank of America. The upcoming earnings release will be pivotal in clarifying the company's direction.
Performance & Financial Health Analysis: Surgery Partners vs Chemed
| Metric | SGRY | CHE |
|---|---|---|
| Market Information | ||
| Market Cap | $2.80B | $6.78B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,195,740 | 194,310 |
| 90 Day Avg. Volume | 1,294,510 | 199,293 |
| Last Close | $20.39 | $435.38 |
| 52 Week Range | $18.87 - $33.37 | $408.42 - $623.61 |
| % from 52W High | -38.90% | -30.18% |
| All-Time High | $69.58 (Jun 21, 2021) | $654.62 (Mar 11, 2024) |
| % from All-Time High | -70.70% | -33.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.04% |
| Quarterly Earnings Growth | 0.08% | -0.26% |
| Financial Health | ||
| Profit Margin (TTM) | -0.06% | 0.12% |
| Operating Margin (TTM) | 0.15% | 0.11% |
| Return on Equity (TTM) | 0.00% | 0.24% |
| Debt to Equity (MRQ) | 108.74 | 12.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.73 | $82.56 |
| Cash per Share (MRQ) | $1.96 | $17.22 |
| Operating Cash Flow (TTM) | $263.90M | $426.78M |
| Levered Free Cash Flow (TTM) | $162.32M | $285.06M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.18% |
| Last 12-Month Dividend | N/A | $1.00 |
Valuation & Enterprise Metrics Analysis: Surgery Partners vs Chemed
| Metric | SGRY | CHE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 2,956.00 | 22.80 |
| Forward P/E | 16.79 | 17.82 |
| PEG Ratio | -35.47 | -0.97 |
| Price to Sales (TTM) | 0.84 | 2.57 |
| Price to Book (MRQ) | 1.54 | 5.37 |
| Market Capitalization | ||
| Market Capitalization | $2.80B | $6.78B |
| Enterprise Value | $8.17B | $6.33B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.52 | 2.52 |
| Enterprise to EBITDA | 12.66 | 14.59 |
| Risk & Other Metrics | ||
| Beta | 1.84 | 0.43 |
| Book Value per Share (MRQ) | $13.73 | $82.56 |
Financial Statements Comparison: Surgery Partners vs Chemed
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SGRY | CHE |
|---|---|---|
| Revenue/Sales | $776.00M | $646.94M |
| Cost of Goods Sold | $614.10M | $430.53M |
| Gross Profit | $161.90M | $216.41M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $89.60M | $94.76M |
| EBITDA | $131.50M | $112.02M |
| Pre-Tax Income | $-300,000 | $95.67M |
| Income Tax | $0 | $23.92M |
| Net Income (Profit) | $-300,000 | $71.76M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SGRY | CHE |
|---|---|---|
| Cash & Equivalents | $229.30M | $173.88M |
| Total Current Assets | $1.07B | $502.39M |
| Total Current Liabilities | $569.40M | $290.56M |
| Long-Term Debt | $3.72B | $102.08M |
| Total Shareholders Equity | $3.59B | $1.18B |
| Retained Earnings | $-775.00M | $2.79B |
| Property, Plant & Equipment | $2.02B | $724.13M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SGRY | CHE |
|---|---|---|
| Operating Cash Flow | $-1.50M | $34.75M |
| Capital Expenditures | $-17.90M | $112,000 |
| Free Cash Flow | $-16.70M | $19.46M |
| Debt Repayment | $-119.30M | N/A |
| Common Stock Repurchase | N/A | $-33.22M |
Short Interest & Institutional Ownership Analysis
| Metric | SGRY | CHE |
|---|---|---|
| Shares Short | 13.22M | 387,671 |
| Short Ratio | 10.18 | 2.17 |
| Short % of Float | 0.22% | 0.03% |
| Average Daily Volume (10 Day) | 1,195,740 | 194,310 |
| Average Daily Volume (90 Day) | 1,294,510 | 199,293 |
| Shares Outstanding | 127.11M | 14.56M |
| Float Shares | 68.52M | 14.29M |
| % Held by Insiders | 0.01% | 0.02% |
| % Held by Institutions | 1.14% | 0.98% |
Dividend Analysis & Yield Comparison: Surgery Partners vs Chemed
| Metric | SGRY | CHE |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.00 |
| Last 12-Month Dividend Yield | N/A | 0.18% |
| 3-Year Avg Annual Dividend | N/A | $1.37 |
| 3-Year Avg Dividend Yield | N/A | 0.08% |
| 3-Year Total Dividends | N/A | $4.10 |
| Ex-Dividend Date | N/A | Nov 18, 2024 |